These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3519030)

  • 1. Cyclosporine A: effectiveness and toxicity in a rat model.
    Dieperink H; Kemp E; Leyssac PP; Starklint H
    Clin Nephrol; 1986; 25 Suppl 1():S46-50. PubMed ID: 3519030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerulotubular function in cyclosporine A treated rats.
    Dieperink H; Leyssac PP; Kemp E; Steinbrückl D; Starklint H
    Clin Nephrol; 1986; 25 Suppl 1():S70-4. PubMed ID: 3708939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketoconazole and cyclosporine A: combined effects on rat renal function and on serum and tissue cyclosporine A concentration.
    Dieperink H; Kemp E; Leyssac PP; Starklint H; Wanscher M; Nielsen J; Jørgensen KA; Faber V; Flachs H
    Clin Nephrol; 1986; 25 Suppl 1():S137-43. PubMed ID: 3708923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term cyclosporin A nephrotoxicity in the rat. Evaluation of a morphological scoring system and of co-treatment with isradipine.
    Starklint H; Hansen HV; Kemp M; Leyssac PP; Kemp E; Dieperink H
    APMIS; 1994 May; 102(5):347-55. PubMed ID: 8024736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotoxicity of FK-506 in the rat. Studies on glomerular and tubular function, and on the relationship between efficacy and toxicity.
    Nielsen FT; Leyssac PP; Kemp E; Starklint H; Dieperink H
    Nephrol Dial Transplant; 1995; 10(3):334-40. PubMed ID: 7540737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotoxicity of cyclosporine A in rats with a diminished renal function.
    Provoost AP; Kaptein L; Van Aken M
    Clin Nephrol; 1986; 25 Suppl 1():S162-7. PubMed ID: 3519023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of cyclosporine A on adaptive hypertrophy after unilateral nephrectomy in the rat.
    Schurek HJ; Neumann KH; Jesinghaus WP; Aeikens B; Wonigeit K
    Clin Nephrol; 1986; 25 Suppl 1():S144-7. PubMed ID: 3708925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of cyclosporine (CyA) nephrotoxicity by synthetic prostaglandins.
    Makowka L; Lopatin W; Gilas T; Falk J; Phillips MJ; Falk R
    Clin Nephrol; 1986; 25 Suppl 1():S89-94. PubMed ID: 3708941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro rat model for cyclosporine-induced proximal tubular toxicity.
    Berty RM; Adler S
    J Lab Clin Med; 1991 Jul; 118(1):17-25. PubMed ID: 2066638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An investigation of cyclosporine A (CyA) nephrotoxicity by lithium clearance].
    Takei K
    Nihon Hinyokika Gakkai Zasshi; 1992 Jan; 83(1):40-7. PubMed ID: 1564825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium entry-blockade with verapamil in cyclosporine A plus ischemia induced acute renal failure in rats.
    Iaina A; Herzog D; Cohen D; Gavendo S; Kapuler S; Serban I; Schiby G; Eliahou HE
    Clin Nephrol; 1986; 25 Suppl 1():S168-70. PubMed ID: 3708928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term cyclosporin nephrotoxicity in the rat: effects on renal function and morphology.
    Dieperink H; Leyssac PP; Starklint H; Kemp E
    Nephrol Dial Transplant; 1988; 3(3):317-26. PubMed ID: 3140107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with verapamil and adenosine triphosphate-MgCl2 reduces cyclosporine nephrotoxicity.
    Sumpio B; Baue AE; Chaudry IH
    Surgery; 1987 Mar; 101(3):315-22. PubMed ID: 2950608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cyclosporine in rats with reduced renal mass.
    Brunner FP; Hermle M; Mihatsch MJ; Thiel G
    Clin Nephrol; 1986; 25 Suppl 1():S148-54. PubMed ID: 3708926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cyclosporin A, gentamicin and furosemide on rat renal function: a lithium clearance study.
    Dieperink H; Leyssac PP; Starklint H; Kemp E
    Clin Exp Pharmacol Physiol; 1987; 14(11-12):825-36. PubMed ID: 3447792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotoxicity of cyclosporin A. A lithium clearance and micropuncture study in rats.
    Dieperink H; Leyssac PP; Starklint H; Kemp E
    Eur J Clin Invest; 1986 Feb; 16(1):69-77. PubMed ID: 3084276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats.
    Saad SY; Najjar TA
    Arch Toxicol; 2005 Sep; 79(9):493-9. PubMed ID: 15940472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine A nephrotoxicity in Goldblatt renovascular hypertension in rats.
    Thiel G; Mihatsch MJ; Stahl RA; Hermle M; Brunner FP
    Clin Nephrol; 1986; 25 Suppl 1():S199-204. PubMed ID: 3519027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mannitol potentiates cyclosporine nephrotoxicity.
    Brunner FP; Hermle M; Mihatsch MJ; Thiel G
    Clin Nephrol; 1986; 25 Suppl 1():S130-6. PubMed ID: 3086006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerulotubular function in cyclosporine-treated rats. A lithium clearance, occlusion time/transit time and micropuncture study.
    Dieperink H; Starklint H; Leyssac PP; Kemp E
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():853-9. PubMed ID: 3991583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.